Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-γ activation and function in lipid homeostasis and energy expenditure

FASEB Journal

Volumn 25, Issue 2, 2011, Pages 754-764

  Jin, Daozhong ^a   Guo, Hong ^a   Bu, So Young ^a   Zhang, Yuanyuan ^a   Hannaford, Jennifer ^a   Mashek, Douglas G ^a   Chen, Xiaoli ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Brown adipose tissue; Rosiglitazone; Thermogenesis insulin sensitization

Indexed keywords

FATTY ACID; GLUCOSE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE; THIAZOLIDINEDINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENERGY EXPENDITURE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HOMEOSTASIS; IN VIVO STUDY; INSULIN SENSITIVITY; LIPID DIET; LIPID HOMEOSTASIS; LIPID HYDROLYSIS; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SUBCUTANEOUS FAT; THERMOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WILD TYPE;

ACUTE-PHASE PROTEINS; ADIPOCYTES; ADIPOSE TISSUE, BROWN; ANIMALS; DIETARY FATS; ENERGY METABOLISM; HOMEOSTASIS; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; LIPOCALINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; ONCOGENE PROTEINS; PPAR GAMMA; THIAZOLIDINEDIONES;

MUS;

EID: 79551616552     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-165175     Document Type: Article

References (38)

1. Akerstrom, B., Flower, D. R., and Salier, J. P. (2000) Lipocalins: unity in diversity. Biochim. Biophys. Acta 1482, 1-8
2. Liu, Q., and Nilsen-Hamilton, M. (1995) Identification of a new acute phase protein. J. Biol. Chem. 270, 22565-22570
3. Devireddy, L. R., Teodoro, J. G., Richard, F. A., and Green, M. R. (2001) Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293, 829-834
4. Yan, Q. W., Yang, Q., Mody, N., Graham, T. E., Hsu, C. H., Xu, Z., Houstis, N. E., Kahn, B. B., and Rosen, E. D. (2007) The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56, 2533-2540
5. Zhang, J., Wu, Y., Zhang, Y., Leroith, D., Bernlohr, D. A., and Chen, X. (2008) The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol. Endocrinol. 22, 1416-1426
6. Tan, B. K., Adya, R., Shan, X., Syed, F., Lewandowski, K. C., O'Hare, J. P., and Randeva, H. S. (2009) Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin. Diabetes Care 32, 129-131
7. Guo, H., Jin, D., Zhang, Y., Wright, W., Bazuine, M., Brockman, D. A., Bernlohr, D. A., and Chen, X. (2010) Lipocalin 2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 59, 1376-1385
8. Rosenfeld, M. G., Lunyak, V. V., and Glass, C. K. (2006) Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20, 1405-1428
9. Rennings, A. J., Smits, P., Stewart, M. W., and Tack, C. J. (2006) Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects. Diabetes Care 29, 581-587
10. Guan, Y., Hao, C., Cha, D. R., Rao, R., Lu, W., Kohan, D. E., Magnuson, M. A., Redha, R., Zhang, Y., and Breyer, M. D. (2005) Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat. Med. 11, 861-866
11. Reginato, M. J., Bailey, S. T., Krakow, S. L., Minami, C., Ishii, S., Tanaka, H., and Lazar, M. A. (1998) A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties. J. Biol. Chem. 273, 32679-32684
12. Gregoire, F. M., Zhang, F., Clarke, H. J., Gustafson, T. A., Sears, D. D., Favelyukis, S., Lenhard, J., Rentzeperis, D., Clemens, L. E., Mu, Y., and Lavan, B. E. (2009) MBX-102/JNJ39659100, a novel peroxisome proliferator- activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. Mol. Endocrinol. 23, 975-988
13. Fukui, Y., Masui, S., Osada, S., Umesono, K., and Motojima, K. (2000) A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes 49, 759-767
14. Tai, T. A., Jennermann, C., Brown, K. K., Oliver, B. B., MacGinnitie, M. A., Wilkison, W. O., Brown, H. R., Lehmann, J. M., Kliewer, S. A., Morris, D. C., and Graves, R. A. (1996) Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation. J. Biol. Chem. 271, 29909-29914
15. Rabelo, R., Camirand, A., and Silva, J. E. (1997) 3′,5′- cyclic adenosine monophosphate-response sequences of the uncoupling protein gene are sequentially recruited during darglitazone-induced brown adipocyte differentiation. Endocrinology 138, 5325-5332
16. Camirand, A., Marie, V., Rabelo, R., and Silva, J. E. (1998) Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle. Endocrinology 139, 428-431
17. Matsuda, J., Hosoda, K., Itoh, H., Son, C., Doi, K., Hanaoka, I., Inoue, G., Nishimura, H., Yoshimasa, Y., Yamori, Y., Odaka, H., and Nakao, K. (1998) Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in wistar fatty rats and in cultured adipocytes. Diabetes 47, 1809-1814
18. Xiang, C. C., Wu, Y. J., Ma, L., Ding, L., Lisinski, I., Brownstein, M. J., Cushman, S. W., and Chen, X. (2007) Characterisation of insulin-resistant phenotype of cultured rat primary adipose cells. Diabetologia 50, 1070-1079
19. Weber, T.M., Joost, H.G., Simpson, I.A., and Cushman, S.W. (1988) The Insulin Receptor, A. R. Liss, New York
20. Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917
21. Dietschy, J. M., and Spady, D. K. (1984) Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res. 25, 1469-1476
22. Lessard, S. J., Rivas, D. A., Chen, Z. P., Bonen, A., Febbraio, M. A., Reeder, D. W., Kemp, B. E., Yaspelkis, B. B.,3rd, and Hawley, J. A. (2007) Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes 56, 1856-1864
23. Kramer, D., Shapiro, R., Adler, A., Bush, E., and Rondinone, C. M. (2001) Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of zucker rats. Metabolism 50, 1294-1300
24. Miyazaki, Y., Glass, L., Triplitt, C., Matsuda, M., Cusi, K., Mahankali, A., Mahankali, S., Mandarino, L. J., and DeFronzo, R. A. (2001) Effect of rosiglitazone on glucose and nonesterified fatty acid metabolism in type II diabetic patients. Diabetologia 44, 2210-2219
25. Gastaldelli, A., Miyazaki, Y., Pettiti, M., Santini, E., Ciociaro, D., Defronzo, R. A., and Ferrannini, E. (2006) The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 91, 806-812
26. Miyazaki, Y., Mahankali, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., Cusi, K., Mandarino, L. J., and DeFronzo, R. A. (2001) Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care 24, 710-719
27. Chao, L., Marcus-Samuels, B., Mason, M. M., Moitra, J., Vinson, C., Arioglu, E., Gavrilova, O., and Reitman, M. L. (2000) Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J. Clin. Invest. 106, 1221-1228
28. Ranganathan, G., Unal, R., Pokrovskaya, I., Yao-Borengasser, A., Phanavanh, B., Lecka-Czernik, B., Rasouli, N., and Kern, P. A. (2006) The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: Effects of obesity, insulin resistance, and TZD treatment. J. Lipid. Res. 47, 2444-2450
29. Kim, J. Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., Jelicks, L. A., Mehler, M. F., Hui, D. Y., Deshaies, Y., Shulman, G. I., Schwartz, G. J., and Scherer, P. E. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117, 2621-2637
30. Burkey, B. F., Dong, M., Gagen, K., Eckhardt, M., Dragonas, N., Chen, W., Grosenstein, P., Argentieri, G., and de Souza, C. J. (2000) Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: Comparison to CL 316,243. Metab. Clin. Exp. 49, 1301-1308
31. Mori, Y., Murakawa, Y., Okada, K., Horikoshi, H., Yokoyama, J., Tajima, N., and Ikeda, Y. (1999) Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 22, 908-912
32. Smith, S. R., De Jonge, L., Volaufova, J., Li, Y., Xie, H., and Bray, G. A. (2005) Effect of pioglitazone on body composition and energy expenditure: A randomized controlled trial. Metabolism 54, 24-32
33. Laplante, M., Festuccia, W. T., Soucy, G., Gelinas, Y., Lalonde, J., Berger, J. P., and Deshaies, Y. (2006) Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism. Diabetes 55, 2771-2778
34. Kohlroser, J., Mathai, J., Reichheld, J., Banner, B. F., and Bonkovsky, H. L. (2000) Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the united states food and drug administration. Am. J. Gastroenterol. 95, 272-276
35. Tordjman, J., Chauvet, G., Quette, J., Beale, E. G., Forest, C., and Antoine, B. (2003) Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J. Biol. Chem. 278, 18785-18790
36. Cadoudal, T., Blouin, J. M., Collinet, M., Fouque, F., Tan, G. D., Loizon, E., Beale, E. G., Frayn, K. N., Karpe, F., Vidal, H., Benelli, C., and Forest, C. (2007) Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Diabetologia 50, 666-675
37. Koliwad, S. K., Streeper, R. S., Monetti, M., Cornelissen, I., Chan, L., Terayama, K., Naylor, S., Rao, M., Hubbard, B., and Farese, R. V., Jr. (2010) DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. J. Clin. Invest. 120, 756-767
38. Boden, G., Homko, C., Mozzoli, M., Showe, L. C., Nichols, C., and Cheung, P. (2005) Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes 54, 880-885